Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ava Keyvani Chahi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Blood|May 31, 2022
PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewalAva Keyvani Chahi, Muluken S Belew, Joshua Xu, et al.
Journal of the American Society of Nephrology : JASN|July 29, 2022
Complementary Nck1/2 Signaling in Podocytes Controls <b></b> Actinin-4-Mediated Actin Organization, Adhesion, and Basement Membrane CompositionClaire E Martin, Noah J Phippen, Ava Keyvani Chahi, et al.
Blood Cancer Discovery|February 10, 2023
In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic TargetAna Vujovic, Laura de Rooij, Ava Keyvani Chahi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Blood|May 31, 2022
PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewalAva Keyvani Chahi, Muluken S Belew, Joshua Xu, et al.
Journal of the American Society of Nephrology : JASN|July 29, 2022
Complementary Nck1/2 Signaling in Podocytes Controls <b></b> Actinin-4-Mediated Actin Organization, Adhesion, and Basement Membrane CompositionClaire E Martin, Noah J Phippen, Ava Keyvani Chahi, et al.
Blood Cancer Discovery|February 10, 2023
In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic TargetAna Vujovic, Laura de Rooij, Ava Keyvani Chahi, et al.
Pageof 2